Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Bepridil

A non-selective calcium channel blocker with a diamine structure, approved in the United States in 1990 for angina pectoris; it has also been studied for atrial fibrillation. This family brings together the active ingredient and other impurities.

Did you know?In 2015, in a screen of already approved drugs, it protected all the mice exposed to Ebola virus; later it also showed activity against SARS-CoV-2 in cell experiments.

BepridilGo to the active ingredient →
BepridilActive ingredientBepridilCat. No. P-B052-001CAS 64706-54-3

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.